First Manhattan CO Regeneron Pharmaceuticals, Inc. Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, First Manhattan CO holds 244 shares of REGN stock, worth $175,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244

Previous 194 25.77%

Holding current value

$175,228

Previous $203,000 26.11%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $51,204 - $60,088	50 Added 25.77%	244 $256,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $883 - $1,071	1 Added 0.52%	194 $203,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $4,513 - $4,966	5 Added 2.66%	193 $185,000
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $775 - $881	1 Added 0.53%	188 $165,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $10,386 - $12,665	-15 Reduced 7.43%	187 $153,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $1.03 Million - $1.12 Million	-1,460 Reduced 87.85%	202 $145,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $134,882 - $170,215	235 Added 16.47%	1,662 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $746,239 - $885,248	1,300 Added 1023.62%	1,427 $863,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $44,673 - $54,820	-100 Reduced 44.05%	127 $60,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $4,902 - $5,923	-9 Reduced 3.81%	227 $127,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $49,332 - $64,391	100 Added 73.53%	236 $147,000
Q1 2020 May 06, 2020	SELL	$336.18 - $494.43 $3,697 - $5,438	-11 Reduced 7.48%	136 $66,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $13,672 - $15,919	-50 Reduced 25.38%	147 $40,000
Q1 2018 Apr 20, 2018	BUY	$315.82 - $393.78 $62,216 - $77,574	197 New	197 $67,000

Others Institutions Holding REGN

# of Institutions

1,533

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Regeneron Pharmaceuticals, Inc. Transaction History